Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infection

Journal of NeuroVirology

Volumn 13, Issue 5, 2007, Pages 433-445

  Trottier, Mark ^a   Lyles, Douglas ^b   Reiss, Carol Shoshkes ^a,c,d  

^a NEW YORK UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cells; Iron production; Viral encephalitis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BETA INTERFERON; INTERFERON; M PROTEIN; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CHEMICAL SYMPATHECTOMY; CONTROLLED STUDY; DENDRITIC CELL; IN VITRO STUDY; INTERFERON INDUCTION; INTERFERON PRODUCTION; LUNG; LYMPH FLOW; LYMPHOID ORGAN; MALE; MOUSE; NEUROEPITHELIUM; NONHUMAN; OLFACTORY NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA VIRUS INFECTION; SPLEEN; VESICULAR STOMATITIS VIRUS; VIRUS DETECTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; INTERFERON TYPE I; MICE; NEUROBLASTOMA; RNA, MESSENGER; VESICULAR STOMATITIS;

MUS; VESICULAR STOMATITIS VIRUS;

EID: 36148985702     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280701460565     Document Type: Article

References (73)

1. Ahmed, M., McKenzie, M. O., Puckett, S., Hojnacki, M., Poliquin, L. and Lyles, D. S. (2003) Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J Virol, 77, pp. 4646-4657.
2. Ambrosini, E., Remoli, M. E., Giacomini, E., Rosicarelli, B., Serafini, B., Lande, R., Aloisi, F. and Coccia, E. M. (2005) Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions. J Neuropathol Exp Neurol, 64, pp. 706-715.
3. Bailey, M., Engler, H., Hunzeker, J. and Sheridan, J. F. (2003) The hypothalamic-pituitary-adrenal axis and viral infection. Viral Immunol, 16, pp. 141-157.
4. Bailey, S. L., Schreiner, B., McMahon, E. J. and Miller, S. D. (2007) CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE. Nat Immunol, 8, pp. 172-180.
5. Barchet, W., Cella, M., Odermatt, B., Asselin-Paturel, C., Colonna, M. and Kalinke, U. (2002) Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J Exp Med, 195, pp. 507-516.
6. Barna, M., Komatsu, T. and Reiss, C. S. (1996) Sex differences in susceptibility to viral infection of the central nervous system. J Neuroimmunol, 67, pp. 31-39.
7. Barna, M., Komatsu, T. and Reiss, C. S. (1996) Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection. Virology, 223, pp. 331-343.
8. Barna, M., Komatsu, T. and Reiss, C. S. (1995) Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J Virol, 69, pp. 6466-6472.
9. Reiss, C. S. (1995) Inhibition of vesicular stomatitis virus infection by nitric oxide. J Virol, 69, pp. 2208-2213.
10. Blalock, J. E. (1989) A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev, 69, pp. 1-32.
11. Boehme, K. W. and Compton, T. (2004) Innate sensing of viruses by toll-like receptors. J Virol, 78, pp. 7867-7873.
12. Breakfield, X. O., Neale, E. A., Neale, J. H. and Jacobowitz, D. M. (1975) Localized catecholamine storage associated with granules in murine neuroblastoma cells. Brain Res, 92, pp. 237-256.
13. Browning, M. J., Huneycutt, B. S., Huang, A. S. and Reiss, C. S. (1991) Replication-defective viruses modulate immune responses. J Immunol, 147, pp. 2685-2691.
14. Campbell, S. J., Perry, V. H., Pitossi, F. J., Butchart, A. G., Chertoff, M., Waters, S., Dempster, R. and Anthony, D. C. (2005) Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am J Pathol, 166, pp. 1487-1497.
15. Chen, G., Ward, M. F., Sama, A. E. and Wang, H. (2004) Extracellular HMGB1 as a proinflammatory cytokine. J Interferon Cytokine Res, 24, pp. 329-333.
16. Chesler, D. A., Munoz-Jordan, J. L., Donelan, N., Garcia-Sastre, A. and Reiss, C. S. (2003) PKR is not required for interferon-gamma inhibition of VSV replication in neurons. Viral Immunol, 16, pp. 87-96.
17. Christian, A. Y., Barna, M. and Reiss, C. S. (1996) Host immune response to vesicular stomatitis virus infection of the central nervous system in C57BL/6 mice. Viral Immunol, 9, pp. 195-205.
18. Conzelmann, K. K. (2005) Transcriptional activation of alpha/beta interferon genes: Interference by nonsegmented negative-strand RNA viruses. J Virol, 79, pp. 5241-5248.
19. Crozat, K. and Beutler, B. (2004) TLR7: A new sensor of viral infection. Proc Natl Acad Sci USA, 101, pp. 6835-6836.
20. Dafny, N. and Yang, P. B. (2005) Interferon and the central nervous system. Eur J Pharmacol, 523, pp. 1-15.
21. Delhaye, S., Paul, S., Blakqori, G., Minet, M., Weber, F., Staeheli, P. and Michiels, T. (2006) Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci USA, 103, pp. 7835-7840.
22. Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S. and Reise, Sousa (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science, 303, pp. 1529-1531.
23. Durbin, J. E., Hackenmiller, R., Simon, M. C. and Levy, D. E. (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell, 84, pp. 443-450.
24. Durbin, R. K., Mertz, S. E., Koromilas, A. E. and Durbin, J. E. (2002) PKR protection against intranasal vesicular stomatitis virus infection is mouse strain dependent. Viral Immunol, 15, pp. 41-51.
25. Ferran, M. C. and Lucas-Lenard, J. M. (1997) The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J Virol, 71, pp. 371-377.
26. Francoeur, A. M., Lam, T. and Stanners, C. P. (1980) PIF, a highly sensitive plaque assay for the induction of interferon. Virology, 105, pp. 526-536.
27. Francoeur, A. M., Poliquin, L. and Stanners, C. P. (1987) The isolation of interferon-inducing mutants of vesicular stomatitis virus with altered viral P function for the inhibition of total protein synthesis. Virology, 160, pp. 236-245.
28. Gaddy, D. F. and Lyles, D. S. (2005) Vesicular stomatitis viruses expressing wild-type or mutant M proteins activate apoptosis through distinct pathways. J Virol, 79, pp. 4170-4179.
29. Georgel, P., Jiang, Z., Kunz, S., Janssen, E., Mols, J., Hoebe, K., Bahram, S., Oldstone, M BA and Beutler, B. Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology, 362, pp. 304-313.
30. Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H. and Bauer, S. (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science, 303, pp. 1526-1529.
31. Herrmann, M. and Ehrenreich, H. (2003) Brain derived proteins as markers of acute stroke: Their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci, 21, pp. 177-190.
32. Hofmann, M. A., Drury, S., Taguchi, A., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., Neurath, M. F., Slattery, T., Beach, D., McClary, J., Nagashima, M., Morser, J., Stern, D. and Schmidt, A. M. (1999) RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides. Cell, 97, pp. 889-901.
33. Huneycutt, B. S., Plakhov, I. V., Shusterman, Z., Bartido, S. M., Huang, A., Reiss, C. S. and Aoki, C. (1994) Distribution of vesicular stomatitis virus proteins in the brains of BALB/c mice following intranasal inoculation: An immunohistochemical analysis. Brain Res, 635, pp. 81-95.
34. Ireland, D. D. and Reiss, C. S. (2004) Expression of IL-12 receptor by neurons. Viral Immunol, 17, pp. 411-422.
35. Ireland, D. D. and Reiss, C. S. (2006) Gene expression contributing to recruitment of circulating cells in response to vesicular stomatitis virus infection of the CNS. Viral Immunol, 19, pp. 536-545.
36. Jiang, Z., Georgel, P., Shamel, L., Sovath, S., Mudd, S., Huber, M., Kalis, C., Keck, S., Galanos, C., Freudenberg, M. and Beutler, B. (2005) CD14 is required for MyD88-independent LPS signaling. Nat Immunol, 6, pp. 565-570.
37. Kawai, T. and Akira, S. (2005) Toll-like receptor downstream signaling. Arthritis Res Ther, 7, pp. 12-19.
38. Komatsu, T. and Reiss, C. S. (1996) Interferon-gamma induced type I nitric oxide synthase activity inhibits viral replication in neurons. J Neuroimmunol, 68, pp. 101-108.
39. Lalla, E., Lamster, I. B., Feit, M., Huang, L., Spessot, A., Kislinger, T., Stern, D. M. and Schmidt, A. M. (2000) Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest, 105, pp. 1117-1124.
40. Liliensiek, B., Weigand, M. A., Bierhaus, A., Nicklas, W., Kasper, M., Hofer, S., Plachky, J., Grone, H. J., Kurschus, F. C., Schmidt, A. M., Yan, S. D., Martin, E., Schleicher, E., Stern, D. M., Hammerling, G. G., Nawroth, P. P. and Arnold, B. (2004) Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest, 113, pp. 1641-1650.
41. Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., Iwasaki, A. and Flavell, R. A. (2004) Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl Acad Sci USA, 101, pp. 5598-5603.
42. Madden, K. S. (2003) Catecholamines, sympathetic innervation, and immunity. Brain Behav Immun, 17, pp. S5-S10.
43. Malmgaard, L. (2005) Dendritic cells, toll-like receptors, and T-cell responses: Lessons from viral infections in vivo. Viral Immunol, 18, pp. 584-594.
44. Marcus, P. I., Rodriguez, L. L. and Sekellick, M. J. (1998) Interferon induction as a quasispecies marker of vesicular stomatitis virus populations. J Virol, 72, pp. 542-549.
45. Marie, I., Durbin, J. E. and Levy, D. E. (1998) Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J, 17, pp. 6660-6669.
46. Matyszak, M. K. and Perry, V. H. (1997) Dendritic cells in inflammatory responses in the CNS. Adv Exp Med Biol, 417, pp. 295-299.
47. McEwen, B. S., Biron, C. A., Brunson, K. W., Bullock, K., Chambers, W. H., Dhabhar, F. S., Goldfarb, R. H., Kitson, R. P., Miller, A. H., Spencer, R. L. and Weiss, J. M. (1997) The role of adrenocorticoids as modulators of immune function in health and disease: Neural, endocrine and immune interactions. Brain Res Brain Res Rev, 23, pp. 79-133.
48. Muller, U., Steinhoff, U., Reis, L. F., Hemmi, S., Pavlovic, J., Zinkernagel, R. M. and Aguet, M. (1994) Functional role of type I and type II interferons in antiviral defense. Science, 264, pp. 1918-1921.
49. Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D. and Shaw, A. (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem, 267, pp. 14998-15004.
50. Newman, T. A., Galea, I., van, R. N. and Perry, V. H. (2005) Blood-derived dendritic cells in an acute brain injury. J Neuroimmunol, 166, pp. 167-172.
51. Petersen, J. M., Her, L. S., Varvel, V., Lund, E. and Dahlberg, J. E. (2000) The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol Cell Biol, 20, pp. 8590-8601.
52. Plakhov, I. V., Aoki, C., Reiss, C. S. and Huang, A. S. (1995) Pathogenesis of murine encephalitis limited by defective interfering particles. An immunohistochemical study. J NeuroVirol, 1, pp. 207-218.
53. Plakhov, I. V., Arlund, E. E., Aoki, C. and Reiss, C. S. (1995) The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system. Virology, 209, pp. 257-262.
54. Publicover, J., Ramsburg, E., Robek, M. and Rose, J. K. (2006) Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: Viral pathogenesis is linked to induction of tumor necrosis factor alpha. J Virol, 80, pp. 7028-7036.
55. Publicover, J., Ramsburg, E. and Rose, J. K. (2005) A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector. J Virol, 79, pp. 13231-13238.
56. Ramsburg, E., Publicover, J., Buonocore, L., Poholek, A., Robek, M., Palin, A. and Rose, J. K. (2005) A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced t-cell responses and is highly attenuated for replication in animals. J Virol, 79, pp. 15043-15053.
57. Rempel, J. D., Murray, S. J., Meisner, J. and Buchmeier, M. J. (2004) Differential regulation of innate and adaptive immune responses in viral encephalitis. Virology, 318, pp. 381-392.
58. Rosicarelli, B., Serafini, B., Sbriccoli, M., Cardone, F., Pocchiari, M. and Aloisi, F. (2005) Migration of dendritic cells into the brain in a mouse model of prion disease. J Neuroimmunol, 165, pp. 114-120.
59. Sabin, A. B. and Olitsky, P. K. (1938) Influence of host factors on neuroinvasiveness of vesicular stomatitis virus: III. Effect of age and pathway of infection on the character and localization of lesions in the central nervous system. J Exp Med, 67, pp. 201-228.
60. Sandberg, K., Eloranta, M. L. and Campbell, I. L. (1994) Expression of alpha/beta interferons (IFN-alpha/beta) and their relationship to IFN-alpha/beta-induced genes in lymphocytic choriomeningitis. J Virol, 68, pp. 7358-7366.
61. Schubert, D., Humphreys, S., Baroni, C. and Cohn, M. (1969) In vitro differentiation of a mouse neuroblastoma. Proc Natl Acad Sci USA, 64, pp. 316-323.
62. Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., Capello, E., Mancardi, G. L. and Aloisi, F. (2006) Dendritic cells in multiple sclerosis lesions: Maturation stage, myelin uptake, and interaction with proliferating T cells. J Neuropathol Exp Neurol, 65, pp. 124-141.
63. Silverman, M. N., Pearce, B. D., Biron, C. A. and Miller, A. H. (2005) Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol, 18, pp. 41-78.
64. Stojdl, D. F., Abraham, N., Knowles, S., Marius, R., Brasey, A., Lichty, B. D., Brown, E. G., Sonenberg, N. and Bell, J. C. (2000) The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J Virol, 74, pp. 9580-9585.
65. Stojdl, D. F., Lichty, B. D., tenOever, B. R., Paterson, J. M., Power, A. T., Knowles, S., Marius, R., Reynard, J., Poliquin, L., Atkins, H., Brown, E. G., Durbin, R. K., Durbin, J. E., Hiscott, J. and Bell, J. C. (2003) VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell, 4, pp. 263-275.
66. Trottier, M., Schlitt, B. P., Kung, A. Y. and Lipton, H. L. (2004) Transition from acute to persistent Theiler's virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease. J Virol, 78, pp. 12480-12488.
67. Trottier, M DJ, Palian, B. M. and Reiss, C Shoshkes (2005) VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. Virology, 333, pp. 215-225.
68. Weihe, E., Nohr, D., Michel, S., Muller, S., Zentel, H. J., Fink, T. and Krekel, J. (1991) Molecular anatomy of the neuro-immune connection. Int J Neurosci, 59, pp. 1-23.
69. Yan, S. S., Wu, Z. Y., Zhang, H. P., Furtado, G., Chen, X., Yan, S. F., Schmidt, A. M., Brown, C., Stern, A., La Faille, J., Chess, L., Stern, D. M. and Jiang, H. (2003) Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system. Nat Med, 9, pp. 287-293.
70. Yang, K., Puel, A., Zhang, S., Eidenschenk, C., Ku, C. L., Casrouge, A., Picard, C., von, B. H., Senechal, B., Plancoulaine, S., Al-Hajjar, S., Al-Ghonaium, A., Marodi, L., Davidson, D., Speert, D., Roifman, C., Garty, B. Z., Ozinsky, A., Barrat, F. J., Coffman, R. L., Miller, R. L., Lebon, P., Rodriguez-Gallego, C., Chapel, H., Geissmann, F., Jouanguy, E. and Casanova, J. L. (2005) Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity, 23, pp. 465-478.
71. Yetter, R. A., Lehrer, S., Ramphal, R. and Small Jr, P. A. (1980) Outcome of influenza infection: Effect of site of initial infection and heterotypic immunity. Infect Immun, 29, pp. 654-662.
72. Zhou, S., Kurt-Jones, E. A., Fitzgerald, K. A., Wang, J. P., Cerny, A. M., Chan, M. and Finberg, R. W. (2007) Role of MyD88 in route-dependent susceptibility to vesicular stomatitis virus infection. J Immunol, 178, pp. 5173-5181.
73. Zozulya, A. L., Reinke, E., Baiu, D. C., Karman, J., Sandor, M. and Fabry, Z. (2007) Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases. J Immunol, 178, pp. 520-529.